Patrice Nasnas

Treatment of relapsed/refractory acute lymphoblastic leukemia.

H. Kantarjian, E. Jabbour, S. Paul, 2019, Clinical advances in hematology & oncology : H&O.

Blinatumomab for the treatment of acute lymphoblastic leukemia: an update

H. Kantarjian, E. Jabbour, S. Paul, 2019, Expert Opinion on Orphan Drugs.

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

H. Kantarjian, E. Jabbour, M. Welch, 2018, Therapeutic advances in hematology.

Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

M. Konopleva, H. Kantarjian, G. Garcia-Manero, 2018, Blood.

How I Manage Chronic Lymphocytic Leukemia

G. Martinelli, A. Ferrajoli, C. Cerchione, 2023, Hematology reports.

Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial

H. Kantarjian, Xuelin Huang, T. Kadia, 2023, Blood.